Solterra Renewable Technologies, Quantum Materials’ wholly owned subsidiary, has entered into a process development agreement with a consortium of advanced chemistry companies in the Netherlands, to validate high volume production methods for its proprietary tetrapod quantum dots. The agreement follows the MOU that Solterra, FutureChemistry and Flowid signed in 2009.
FutureChemistry and Flowid will provide the expertise necessary to find optimal process conditions and scale the synthesis of the quantum dots to necessary levels. With larger quantities of quantum dots, Solterra will be enabled to pursue its goal of reaching 1GW of solar cell production. Solterra aims to increase available solar energy generation and to bring low cost quantum dots to the LED, display, broader optoelectronic and biomedical research markets.
Pieter Nieuwland, research director of FutureChemistry said, “Testing new chemical reactions is often performed in a traditional way: step by step. With the technology of FutureChemistry and Flowid, these reactions become full-continuous processes that we can optimize with our software and translate to much larger reactors. This project will be an exciting showcase for flow chemistry, and it will prove that the technology is now reaching maturity.”
Stephen Squires, Solterra CEO said, “We are very pleased with this collaboration and are eagerly looking forward to fruitful efforts with both FutureChemistry and Flowid. Their leading edge work essentially allows the company to overcome barriers to entry of high volume, high tech markets. The imminent ability to sell stand alone quantum dots in large quantities at attractive pricing into various markets, while continuing to develop breakthrough solar cell technology, undoubtedly will generate significant revenue for Solterra, Quantum Materials and its shareholders.”